- AMO said it “revolutionized cataract surgery” through the use of advanced imaging technology called optical coherence tomography, which allows surgeons to control the laser when accessing the diseased lens so it can be removed and replaced with an artificial one
- It has enabled cataract surgery “to be performed precisely, consistently and safely,” according to the complaint filed Tuesday in federal court in Wilmington, Del.
- NOTE: Patented technology is used in J&J Surgical Vision’s Catalys Precision Laser System, which competes ...
Learn more about Bloomberg Law or Log In to keep reading:
See Breaking News in Context
Bloomberg Law provides trusted coverage of current events enhanced with legal analysis.
Already a subscriber?
Log in to keep reading or access research tools and resources.